European Journal of Pain

Last updated

Related Research Articles

In a blind or blinded experiment, information which may influence the participants of the experiment is withheld until after the experiment is complete. Good blinding can reduce or eliminate experimental biases that arise from a participants' expectations, observer's effect on the participants, observer bias, confirmation bias, and other sources. A blind can be imposed on any participant of an experiment, including subjects, researchers, technicians, data analysts, and evaluators. In some cases, while blinding would be useful, it is impossible or unethical. For example, it is not possible to blind a patient to their treatment in a physical therapy intervention. A good clinical protocol ensures that blinding is as effective as possible within ethical and practical constraints.

BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. It was founded in 2000 and has been owned by Springer, now Springer Nature, since 2008.

Duloxetine Medication

Duloxetine, sold under the brand name Cymbalta among others, is a medication used to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain. It is taken by mouth.

The Institute for Scientific Information (ISI) was an academic publishing service, founded by Eugene Garfield in Philadelphia in 1956. ISI offered scientometric and bibliographic database services. Its specialty was citation indexing and analysis, a field pioneered by Garfield.

<i>British Journal of Pharmacology</i> Academic journal

The British Journal of Pharmacology is a biweekly peer-reviewed medical journal covering all aspects of experimental pharmacology. It is published for the British Pharmacological Society by Wiley-Blackwell. It was established in 1946 as the British Journal of Pharmacology and Chemotherapy. The journal obtained its current title in 1968.

Flupirtine

Flupirtine is an aminopyridine that functions as a centrally acting non-opioid analgesic that was originally used as an analgesic for acute and chronic pain but in 2013 due to issues with liver toxicity, the European Medicines Agency restricted its use to acute pain, for no more than two weeks, and only for people who cannot use other painkillers. In March 2018, marketing authorisations for flupirtine were withdrawn following a European Medicines Agency recommendation based on the finding that the restrictions introduced in 2013 had not been sufficiently followed in clinical practice, and cases of serious liver injury still occurred including liver failure.

<i>Clinical and Experimental Pharmacology and Physiology</i> Academic journal

Clinical and Experimental Pharmacology and Physiology is a peer-reviewed scientific journal that publishes articles relating to pharmacology and physiology.

<i>European Journal of Clinical Pharmacology</i> Academic journal

The European Journal of Clinical Pharmacology is a peer-reviewed medical journal published by Springer Science+Business Media since 1968. It covers all aspects of clinical pharmacology and drug therapy in humans.

Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.

Palmitoylethanolamide (PEA) is an endogenous fatty acid amide, belonging to the class of nuclear factor agonists. PEA has been studied in in vitro and in vivo systems using exogenously added or dosed compound; there is evidence that it binds to a nuclear receptor, through which it exerts a variety of biological effects, some related to chronic inflammation and pain.

Clinical and Translational Science is a bimonthly peer-reviewed open-access medical journal covering translational medicine. It is published by Wiley-Blackwell and is an official journal of the American Society for Clinical Pharmacology and Therapeutics. The journal was established in 2008 and the editor-in-chief is John A. Wagner.

<i>Drugs</i> (journal) Academic journal

Drugs is a peer-reviewed medical journal published by Adis International that covers topics in drugs and therapeutics. Besides research articles, the journal also publishes "Adis Drug Evaluations and AdisInsight Reports", evidence-based, single-agent reviews.

<i>Cardiology</i> (journal) Academic journal

Cardiology: International Journal of Cardiovascular Medicine, Surgery, Pathology and Pharmacology is a monthly peer-reviewed medical journal published by Karger. The editor is Dan Atar. It was established in 1937 as Cardiologia by Bruno Kisch and Wilhelm Löffler. From 1971, the journal was published under the name Cardiology and in 2005 it incorporated the medical journal Heart Drug and obtained its current name.

<i>Thorax</i> (journal) Academic journal

Thorax is a monthly peer-reviewed medical journal specialising in both clinical and experimental research articles on respiratory medicine as well as paediatrics, immunology, pharmacology, pathology, and surgery. It was established in 1946 and is published by the BMJ Group on behalf of the British Thoracic Society. The journal is available online by subscription and archived editions of the journal are available free of charge after 1 year. The editors-in-chief are Alan Smyth, Gisli Jenkins and Nicholas Hart.

<i>Journal of Antimicrobial Chemotherapy</i> Academic journal

The Journal of Antimicrobial Chemotherapy is a peer-reviewed medical journal which covers antimicrobial chemotherapy, including laboratory aspects and clinical use of antimicrobial agents. It is published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy and was established in 1975. In January 2015 J. Peter Donnelly became the eighth editor-in-chief replacing Alan P. Johnson. The journal has had two previous publishers. All content is available for free after 12 months while authors also have the option to have their articles published immediately as open access.

European Neuropsychopharmacology is a monthly peer-reviewed scientific journal published by Elsevier. It is the official journal of the European College of Neuropsychopharmacology. It was established in November 1990 and covers clinical and basic research relevant to the effects of centrally acting agents in its broadest sense.

<i>Clinical Therapeutics</i> Academic journal

Clinical Therapeutics is a monthly peer-reviewed medical journal that was established in 1977 and is published by Elsevier. It is an official journal of the European Association for Clinical Pharmacology and Therapeutics. The journal covers all aspects of clinical pharmacology and therapeutics.

Oliceridine

Oliceridine, sold under the brand name Olinvyk, is an opioid medication that is used for the treatment of moderate to severe acute pain in adults. It is given by intravenous (IV) injection.

The Clinical Neuropharmacology is a peer-reviewed bimonthly journal publishes original articles, brief reports, reviews devoted to the pharmacology of the nervous system in its broadest sense. According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.009. The journal ranks 148/254 among Pharmacology & Pharmacy and 116/192 Clinical Neurology.

References

  1. "European Journal of Pain". 2018 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2019.